Royalty Pharma IPO prices at top of range in biggest 2020 U.S. listing -sources
June 15, 2020 at 19:36 PM EDT
Royalty Pharma is set to sell shares in its U.S. initial public offering (IPO) at the top end its target range, in the biggest U.S. listing of the year so far, according to people familiar with the matter.
